Bioceltix (WAR:BCX) FCF Margin %: 0.00% (As of Mar. 2026)


WAR:BCX Bioceltix SA WAR:BCX
21 GF Score
Price zł87.80
! 1 Warning Sign
View Full Analysis

What is Bioceltix FCF Margin %?

Bioceltix WAR:BCX +0.11% 21 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates WAR:BCX with a GF Score™ of 21/100. The stock has 1 warning sign investors should review. Among 960 Biotechnology companies, Bioceltix ranks worse than 104166.56% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bioceltix's Free Cash Flow for the three months ended in Mar. 2026 was zł-7.55 Mil. Bioceltix's Revenue for the three months ended in Mar. 2026 was zł0.00 Mil. Therefore, Bioceltix's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Bioceltix's current FCF Yield % is -4.27%.

The historical rank and industry rank for Bioceltix's FCF Margin % or its related term are showing as below:


During the past 7 years, the highest FCF Margin % of Bioceltix was -15354.55%. The lowest was -92400.00%. And the median was -53877.28%.

WAR:BCX's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -85.21
* Ranked among companies with meaningful FCF Margin % only.

Bioceltix FCF Margin % Related Terms

Bioceltix FCF Margin % Historical Data

* Premium members only.

The historical data trend for Bioceltix's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioceltix FCF Margin % Chart

Bioceltix Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Bioceltix Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

WAR:BCX vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Bioceltix's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioceltix FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioceltix's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Bioceltix's FCF Margin % falls into.


WAR:BCX
21GF Score
Bioceltix SA WAR:BCX
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioceltix FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Bioceltix's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-13.92/0
= %

Bioceltix's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-7.549/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Bioceltix (WAR:BCX) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bioceltix and its competitors. According to the industry distribution chart, Bioceltix ranks #999999 out of 960 companies in the Biotechnology industry.
Is Bioceltix's FCF Margin % too high?
Bioceltix's current FCF Margin % is 0.00%. Based on the distribution chart, Bioceltix ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Bioceltix has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Bioceltix's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bioceltix ranks #999999 out of 960 companies for FCF Margin %. This places Bioceltix in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bioceltix and its competitors. Bioceltix's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioceltix stock overvalued right now?
Bioceltix (WAR:BCX) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Bioceltix's overall GF Score™ is 21/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Bioceltix (WAR:BCX), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioceltix Business Description

Address Bierutowska 57-59 Street, Wroclaw, POL, 51-317
Bioceltix SA develops therapies for veterinary use that harness the immunomodulatory properties of mesenchymal stem cells. Its pipeline products include BCX-CM-J for Degenerative joint lesions; BCX-CM-S for Autoimmune and inflammatory diseases in dogs; BCX-EM for Tendon damage and BCX-FM for Gingivostomatitis.
21GF Score

Get the complete analysis for WAR:BCX

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł87.80
Price